Breast Adenocarcinoma — Trials

Breast Adenocarcinoma — Trials · CancerIndex

Clinical trials

Registered studies

1,713 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.

Active: 686
Recruiting: 382
Ph III recruiting: 46
Growth YoY: +5.3%
Industry share: 24%
Top sponsor: Fudan University
Termination share: 44.4%

Computedformula ci-trial-intel-v1 · interventional studies · entity + NCIt descendants · hover a figure for its formulaCompare cancers Terminated studies (278)

clinicaltrialsPublishedShowing 401–450 of 778 studies matching the filters · status and phase as posted by the registrant; each row links to the study record.

NCT	Title	Status	Phase	Enrollment (n)	Sponsor	Countries	Last update	Source
NCT06547840	A Study of MOv18 IgE in Patients With Solid Tumours That Express Folate Receptor Alpha	recruiting	Phase 1	45	Epsilogen LtdINDUSTRY	1	Apr 6, 2026	clinicaltrials
NCT07112053	A Vaccine (STEMVAC) With Standard Endocrine-Based Therapy or Chemotherapy for the Treatment of Metastatic Hormone Receptor Positive, HER2 Negative Breast Cancer	recruiting	Phase 2	40	University of WashingtonOTHER	1	Apr 6, 2026	clinicaltrials